Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Takaji Matsutani"'
Autor:
Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Kazuhiko Doi, Hironori Sakai, Tomoki Sasaki, Takahiro Kusakabe, Sakuya Matsumoto, Yasuyuki Saito, Shinichiro Kawamoto, Katsuya Yamamoto, Taiji Koyama, Yoshiaki Nagatani, Keiji Kurata, Shiro Kimbara, Yoshinori Imamura, Naomi Kiyota, Mitsuhiro Ito, Hironobu Minami
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 661-668 (2024)
Abstract Monovalent Omicron XBB.1.5 mRNA vaccines were newly developed and approved by the FDA in Autumn 2023 for preventing COVID‐19. However, clinical efficacy for these vaccines is currently lacking. We previously established the quantification
Externí odkaz:
https://doaj.org/article/4e80912d8731416b882b2610fa7fdb8e
Autor:
Goh Ohji, Yohei Funakoshi, Kimikazu Yakushijin, Takaji Matsutani, Tomoki Sasaki, Takahiro Kusakabe, Sakuya Matsumoto, Taiji Koyama, Yoshiaki Nagatani, Keiji Kurata, Shiro Kimbara, Naomi Kiyota, Hironobu Minami
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. However, clinical efficacy data for this vaccine are currently lacking. We
Externí odkaz:
https://doaj.org/article/59a011b3f9d04db7af323572148f920d
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/36197e634cc842c99c6094aa82def9b1
Autor:
Hiroaki Hiramatsu, Kisato Nosaka, Shigeru Kusumoto, Nobuaki Nakano, Ilseung Choi, Makoto Yoshimitsu, Yoshitaka Imaizumi, Michihiro Hidaka, Hidenori Sasaki, Junya Makiyama, Eiichi Ohtsuka, Tatsuro Jo, Masao Ogata, Asahi Ito, Kentaro Yonekura, Hiro Tatetsu, Takeharu Kato, Toshiro Kawakita, Youko Suehiro, Kenji Ishitsuka, Shinsuke Iida, Takaji Matsutani, Hiroyoshi Nishikawa, Atae Utsunomiya, Ryuzo Ueda, Takashi Ishida
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/7a719b715c4f446799368076060e4e23
Autor:
Yohei Funakoshi, Goh Ohji, Kimikazu Yakushijin, Kei Ebisawa, Yu Arakawa, Jun Saegusa, Hisayuki Matsumoto, Takamitsu Imanishi, Eriko Fukuda, Takaji Matsutani, Yasuko Mori, Kentaro Iwata, Hironobu Minami
Publikováno v:
Heliyon, Vol 7, Iss 8, Pp e07748- (2021)
Background: Antibody production is one of the primary mechanisms for recovery from coronavirus disease 2019 (COVID-19). It is speculated that massive clonal expansion of B cells, which can produce clinically meaningful neutralizing antibodies, occurs
Externí odkaz:
https://doaj.org/article/8b33ab3692df44f9b5d9e79c219d5924
Autor:
Kazutaka Kitaura, Hiroshi Yamashita, Hitomi Ayabe, Tadasu Shini, Takaji Matsutani, Ryuji Suzuki
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
A diverse antibody repertoire is primarily generated by the rearrangement of V, D, and J genes and subsequent somatic hypermutation (SHM). Class-switch recombination (CSR) produces various isotypes and subclasses with different functional properties.
Externí odkaz:
https://doaj.org/article/287b82b1213e4187b7f830890fa9be2a
Autor:
Hiroaki Shigematsu, Kenichi Kumagai, Hiroshi Kobayashi, Takanori Eguchi, Kazutaka Kitaura, Satsuki Suzuki, Tatsuya Horikawa, Takaji Matsutani, Kouetsu Ogasawara, Yoshiki Hamada, Ryuji Suzuki
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e85983 (2014)
Chromium (Cr) causes delayed-type hypersensitivity reactions possibly mediated by accumulating T cells into allergic inflamed skin, which are called irritants or allergic contact dermatitis. However, accumulating T cells during development of metal a
Externí odkaz:
https://doaj.org/article/cd1b748aab9d48cdb42b821e7161b991
Autor:
Hiroshi Kobayashi, Kenichi Kumagai, Takanori Eguchi, Hiroaki Shigematsu, Kazutaka Kitaura, Mitsuko Kawano, Tatsuya Horikawa, Satsuki Suzuki, Takaji Matsutani, Kouetsu Ogasawara, Yoshiki Hamada, Ryuji Suzuki
Publikováno v:
PLoS ONE, Vol 8, Iss 10, p e76385 (2013)
Metal allergy is categorized as a delayed-type hypersensitivity reaction, and is characterized by the recruitment of lymphocytes into sites of allergic inflammation. Because of the unavailability of suitable animal models for metal allergy, the role
Externí odkaz:
https://doaj.org/article/0c20eac7209e41e3a291aec5eb67f206
Autor:
Yoshiki Fujii, Kazutaka Kitaura, Takaji Matsutani, Kenji Shirai, Satsuki Suzuki, Tomohiko Takasaki, Kenichi Kumagai, Yoshie Kametani, Takashi Shiina, Shuji Takabayashi, Hideki Katoh, Yoshiki Hamada, Ichiro Kurane, Ryuji Suzuki
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56296 (2013)
The common marmoset (Callithrix jacchus) is considered a novel experimental animal model of non-human primates. However, due to antibody unavailability, immunological and pathological studies have not been adequately conducted in various disease mode
Externí odkaz:
https://doaj.org/article/a49cfe0709584ebfa5a37afa95255f32
Autor:
Takaji Matsutani, Eiichi Ohtsuka, Yoshitaka Imaizumi, Kenji Ishitsuka, Asahi Ito, Makoto Yoshimitsu, Kentaro Yonekura, Ilseung Choi, Atae Utsunomiya, Kisato Nosaka, Nobuaki Nakano, Shinsuke Iida, Ryuzo Ueda, Michihiro Hidaka, Toshiro Kawakita, Takashi Ishida, Youko Suehiro, Junya Makiyama, Hiro Tatetsu, Hidenori Sasaki, Shigeru Kusumoto, Takeharu Kato, Tatsuro Jo, Masao Ogata
Publikováno v:
British Journal of Haematology. 196:629-638
'Monitoring of immune responses following mogamulizumab-containing treatment in patients with adult T-cell leukaemia-lymphoma (ATL)' (MIMOGA) is a multicentre prospective clinical study (UMIN000008696). In the MIMOGA study, we found that a lower perc